Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction

European Journal of Heart Failure

Volumn 9, Issue 3, 2007, Pages 258-265

  Corell, Pernille ^a   Gustafsson, Finn ^b   Schou, Morten ^a   Markenvard, John ^c   Nielsen, Tonny ^d   Hildebrandt, Per ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c Fredericia Sygehus   (Denmark)

^d ESBJERG HOSPITAL   (Denmark)

Author keywords

Atrial fibrillation; Heart failure; Prognosis; Systolic function

Indexed keywords

AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; PRIORITY JOURNAL; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; STROKE; SYSTOLIC DYSFUNCTION;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CAUSE OF DEATH; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847256398     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.08.004     Document Type: Article

References (33)

1. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., and Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271 (1994) 840-844
2. Carson P.E., Johnson G.R., Dunkman W.B., Fletcher R.D., Farrell L., and Cohn J.N. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 87 (1993) VI102-VI110
3. Cleland J.G., Swedberg K., Follath F., Komajda M., Cohen-Solal A., Aguilar J.C., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
4. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., and Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32 (1998) 695-703
5. Joglar J.A., Acusta A.P., Shusterman N.H., Ramaswamy K., Kowal R.C., Barbera S.J., et al. Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. Am Heart J 142 (2001) 498-501
6. Middlekauff H.R., Stevenson W.G., and Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84 (1991) 40-48
7. Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J., Michelson E.L., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 (2003) 759-766
8. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., Kober L., Sandoe E., Egstrup K., et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 341 (1999) 857-865
9. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-35.
10. Clark D.M., Plumb V.J., Epstein A.E., and Kay G.N. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 30 (1997) 1039-1045
11. Van GI., Crijns H.J., Blanksma P.K., Landsman M.L., Posma J.L., van den Berg M.P., et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 72 (1993) 560-566
12. Ahmed A., Thornton P., Perry G.J., Allman R.M., and DeLong J.F. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 6 (2004) 421-426
13. Aronow W.S., Ahn C., and Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm. Am J Cardiol 87 (2001) 224-229
14. Crijns H.J., Tjeerdsma G., de Kam P.J., Boomsma F., Van G.I., van den Berg M.P., et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21 15 (2000) 1238-1245
15. Mahoney P., Kimmel S., DeNofrio D., Wahl P., and Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 83 (1999) 1544-1547
16. Swedberg K., Olsson L.G., Charlesworth A., Cleland J., Hanrath P., Komajda M., et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26 13 (2005) 1303-1308
17. Gustafsson F., Ulriksen H., Villadsen H., Nielsen H., Andersen B.B., and Hildebrandt R. Prevalence and characteristics of heart failure clinics in Denmark-design of the Danish heart failure clinics network. Eur J Heart Fail 7 (2005) 283-284
18. Galatius S., Gustafsson F., Nielsen P.H., Atar D., and Hildebrandt P.R. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J 144 (2002) E2
19. Kober L., Torp-Pedersen C., Carlsen J., Videbaek R., and Egeblad H. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. Eur Heart J 15 (1994) 1616-1620
20. Andersen T.F., Madsen M., Jorgensen J., Mellemkjoer L., and Olsen J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46 (1999) 263-268
21. Maggioni A.P., Anand I., Gottlieb S.O., Latini R., Tognoni G., and Cohn J.N. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 40 (2002) 1414-1421
22. Mathew J., Hunsberger S., Fleg J., Mc S.F., Williford W., and Yusuf S. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 118 (2000) 914-922
23. Vermes E., Tardif J.C., Bourassa M.G., Racine N., Levesque S., White M., et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 107 (2003) 2926-3931
24. Roche F., Gaspoz J.M., Da C.A., Isaaz K., Duverney D., Pichot V., et al. Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing Clin Electrophysiol 25 (2002) 1587-1593
25. Stevenson W.G., Stevenson L.W., Middlekauff H.R., Fonarow G.C., Hamilton M.A., Woo M.A., et al. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 28 (1996) 1458-1463
26. Pedersen O.D., Bagger H., Kober L., and Torp-Pedersen C. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction. Int J Cardiol 100 (2005) 65-71
27. Parkash R., Maisel W.H., Toca F.M., and Stevenson W.G. Atrial fibrillation in heart failure: high mortality risk even if ventricular function is preserved. Am Heart J 150 (2005) 701-706
28. van den Berg M.P., Van G. I., and Van Veldhuisen D.J. Impact of atrial fibrillation on mortality in patients with chronic heart failure. Eur J Heart Fail 4 (2002) 571-575
29. Friberg J., Scharling H., Gadsboll N., Truelsen T., and Jensen G.B. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol 94 (2004) 889-894
30. Frost L., Engholm G., Johnsen S., Moller H., and Husted S. Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. Am J Med 108 (2000) 36-40
31. Wolf P.A., Mitchell J.B., Baker C.S., Kannel W.B., and D'Agostino R.B. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158 (1998) 229-234
32. Van G. I., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
33. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833